Elizabeth Beckford-Brathwaite

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The Medical Oncology Centre of Rosebank

Reliant Medical Group

Desert Regional Medical Center

Martin Luther University Halle-Wittenberg

Elizabeth Beckford-Brathwaite is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in adverse effects of chemotherapy, pharmacology, and chemotherapy-induced nausea prevention.

Publications per year

2015–2018

Publications

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial

Cindy Weinstein, Karin Jordan, S.A. Green et al. · Annals of Oncology · 2015 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial

Cindy Weinstein, Karin Jordan, Stuart A. Green et al. · Supportive Care in Cancer · 2018 · 12 citations

Medicine, Oncology, Pharmacology +12

1–2 of 2